glp-1 news november 25 2025 ISPOR 2025: Exploring reasons for discontinuation How Pharmacy Plans Are Managing

Psychological support can be valuable when undertaking significant lifestyle changes

SURMOUNT-4 looked at weight maintenance

The post cites the SUSTAIN and SELECT trials, which it says showed adverse event rates comparable to placebo in many cases

Saturated Fats and Health: A Reassessment and Proposal for Food-Based Recommendations: JACC State-of-the-Art Review

In individuals with type 2 diabetes, another phase 2 clinical study demonstrated that after 12 weeks of efinopegdutide treatment, although no significant improvement in glycated hemoglobin (HbA1c) levels was observed, the effect on weight loss reached a high of 7.9%, well above the 0.7% weight reduction rate in the placebo group

All patients should be educated on recognising and managing hypoglycaemia symptoms